Innsbruck, Austria

Bettina Sailer


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Bettina Sailer and Her Contributions to Pharmaceutical Science

Introduction

Bettina Sailer is a prominent inventor based in Innsbruck, Austria. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative analgesics and opioid antagonists. Her work has the potential to impact pain management and therapeutic applications in medicine.

Latest Patents

Bettina Sailer holds a patent for "Morphinan derivatives, the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof." This invention relates to a class of morphinan compounds and quaternary ammonium salts that may be utilized as highly active analgesics or opioid antagonists. The patent also covers pharmaceutically acceptable salts and easily produced derivatives, along with the processes for their production and use in pharmaceutical specialties.

Career Highlights

Bettina Sailer is associated with Alcasynn Pharmaceuticals GmbH, where she continues to advance her research and development efforts. Her innovative approach to drug formulation and synthesis has garnered attention in the pharmaceutical community.

Collaborations

Throughout her career, Bettina has collaborated with esteemed colleagues, including Helmut Schmidhammer and Mariana Spetea. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Bettina Sailer's contributions to the field of pharmaceutical science exemplify her dedication to innovation and research. Her patent on morphinan derivatives showcases her commitment to developing effective analgesics and opioid antagonists. Through her work, she continues to pave the way for advancements in pain management and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…